Fibromodulin formulation for reducing corneal scarring
AssigneeThe Regents of the University of California
InventorChia Soo
Life of this patent
Estimating the term…
Abstract
A formulation for reducing corneal scarring and related eye conditions, is disclosed. The formulation comprises an effective amount of fibromodulin and can be administered intraocularly, such as by topical application, injection into the eye, or implantation in or on the eye.
Claims22
A method for reducing corneal scarring in a patient comprising intraocularly administering to an injured corneal tissue in a patient a composition comprising an effective amount of fibromodulin in a pharmaceutically acceptable formulation effective for reducing corneal scarring in the patient.
An eye formulation, comprising an effective amount of fibromodulin effective for reducing scarring in an injured tissue of a human being and a pharmaceutically acceptable carrier.
A kit, comprising a composition that comprises an effective amount of fibromodulin, and an applicator for applying the composition to an eye of a patient.
Dependencies are inferred from the claim text.